In human coronary arteries, heart failure is associated with down-regulation of AT1 and AT2 receptors, and increasing age in heart failure patients further diminishes AT1 receptor expression and angiotensin II-induced vasoconstriction.
Answers are grounded in this paper and cite their sources.
Does not alter clinical use of ARBs in HF; leaves open age-specific vascular receptor targeting for future trials.
Angiotensin II is a potent vasoconstrictor that is implicated in the pathogenesis of hypertension, heart failure and atherosclerosis. In the present study, angiotensin II receptor mRNA expression levels were quantified by real-time polymerase chain reaction and the vasocontractile responses to angiotensin II were characterised by in vitro pharmacology in endothelium-denuded human coronary arteries. Angiotensin II type 1 (AT(1)) and type 2 (AT(2)) receptor mRNA expression levels were significantly down-regulated in arteries from patients with heart failure as compared to controls. The angiotensin II-induced vasoconstriction diminished with increasing age in patients with heart failure (r(2)=0.31, P<0.05). Also, the AT(1) receptor mRNA expression levels decreased with increasing age in patients with heart failure (r(2)=0.74, P<0.05), while no such correlation could be shown in the control group (r(2)=0.04, P=n.s.). The AT(2) receptor mRNA expression levels did not correlate with age in patients with heart failure or controls. In conclusion, the diminished angiotensin II vasoconstriction with age in heart failure patients is most likely due to a lower density of AT(1) receptors and may result from a longer period of exposure to heart failure in older patients.
No takes yet. Share an insight, caveat, or question.
Wackenfors et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: